Home/ Supplements/ Omega 3/ Ultra Strength One-per-Day RxOmega-3

Ultra Strength One-per-Day RxOmega-3

product on market Softgel Capsule Natural Factors Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Pharmaceutical grade fish oil concentrate provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health and managing triglyceride levels. Research indicates these compounds contribute to cognitive function and inflammatory response. The overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ultra Strength One-per-Day RxOmega-3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
Cholesterol
5 mg (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Enteripure Softgel Vitamin E
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested usage: 1 softgel per day or as directed by a health professional.

Warnings & Precautions

Cautions: As with any supplement, consult your health professional before use if you are pregnant, breastfeeding, or trying to conceive, or if you are taking medication, have a medical condition, or anticipate a surgery.

Keep out of the reach of children.

Sealed for your protection. Do not use if seal is broken.

Formulation Notes

Ultra Strength One-per-Day RxOmega-3 is a pharmaceutical-grade fish oil providing one of the most powerful strengths of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) available.

Molecularly distilled and guaranteed for purity and safety from environmental pollutants like PCBs and mercury or other harmful compounds, RxOmega-3 surpasses the strictest international standards for quality.

One serving (1 softgel) of Ultra Strength RxOmega-3 provides 600 mg of EPA and 300 mg of DHA omega-3 fatty acids for convenient 'all you need is one per day'.

Ultra Strength One-per-Day RxOmega-3 Enteripure softgels offer targeted delivery using a technology that embeds pure and natural source ingredients into the softgel casing to prevent them from breaking down in the stomach, ensuring no fishy aftertaste.

Manufactured by Natural Factors to ensure safety and potency in accordance with Good Manufacturing Practices (GMP) of the FDA and Health Canada.

Contains no artificial colors, preservatives, or sweeteners; no dairy, sugar, wheat, gluten, yeast, soy, corn, egg, shellfish, salt, tree nuts, or GMOs.

Pharmaceutical grade fish oil 900 mg EPA/DHA

Cardiovascular health

Additional Information

isura Non-GMO - Mass Spec Documentation Lab tested

RxOmega-3 is also available with 25 mcg (1000 IU) vitamin D3.

For freshness, store in a cool, dry place.

Product of Canada Recyclable container and label.

Purity & Potency Guaranteed

Metadata

Product Details

UPC / SKU0 68958 35490 3
DSLD Entry Date2020-05-22
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID220822
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.